TARRYTOWN, N.Y., Oct. 25, 2019 /PRNewswire/ --
Regeneron is the most highly ranked company over the past
decade
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today
announced that the company was once again ranked as a top company
to work for by Science magazine in its annual Top Employers
Survey of the global biotech and pharmaceutical industry.
Regeneron has placed either first or second for each of the past
nine years, making it the most highly ranked company over the past
decade. This year, Regeneron placed second based on 7,658 responses
from people across the industry. The company received particularly
high scores on measures of innovation, being socially responsible
and having company values that align with employee values.
"Good science cannot succeed without good values, and at
Regeneron, we take great pride in our role as a responsible
corporate citizen that drives an unmatched employee experience,"
said Leonard S. Schleifer, M.D.,
Ph.D., President and Chief Executive Officer. "Regeneron strives to
be a leading example of a company creating lasting value for
society, and a place where colleagues want to remain and
contribute. We're grateful that these attributes have been
reflected in the Science survey, year after year."
"In a beleaguered industry, it's important to honor the
innovative and passionate people who are working everyday to
improve the health of others around the globe," said George D. Yancopoulos, M.D., Ph.D., President
and Chief Scientific Officer. "We are so proud that our industry
peers have recognized our special culture for the ninth year in a
row, as our exceptional team continues to push the boundaries of
science and technology. I am also gratified to see other
biotechnology companies with similar values succeed, like our
collaborators at Alnylam who this year took the top ranking."
The Science and Science Careers'
2019 annual Top Employers Survey polled employees in the
biotechnology, biopharmaceutical, pharmaceutical, and related
industries to determine the 20 best employers in these industries
as well as their driving characteristics. Respondents to the
web-based survey were asked to rate companies based on 23
characteristics. Survey respondents came from North America (72%), Europe (19%), Asia/Pacific Rim (7%), and other regions (2%). More
information is available at
www.sciencecareers.org/TopEmployers2019.
About Regeneron
Regeneron (NASDAQ: REGN) is a leading
biotechnology company that invents life-transforming medicines for
people with serious diseases. Founded and led for 30 years by
physician-scientists, our unique ability to repeatedly and
consistently translate science into medicine has led to seven
FDA-approved treatments and numerous product candidates in
development, all of which were homegrown in our laboratories. Our
medicines and pipeline are designed to help patients with eye
diseases, allergic and inflammatory diseases, cancer,
cardiovascular and metabolic diseases, neuromuscular diseases,
infectious diseases and rare diseases.
Regeneron is accelerating and improving the traditional drug
development process through our
proprietary VelociSuite® technologies,
including VelocImmune® which uses a unique
genetically-humanized mouse to produce optimized fully-human
antibodies and bispecific antibodies, and through ambitious
research initiatives such as the Regeneron Genetics Center, which
is conducting one of the largest genetics sequencing efforts in the
world.
For additional information about the company, please visit
www.regeneron.com or follow @Regeneron on Twitter.
Regeneron Media Relations
Ella Campbell
Tel: +1
(914) 847-7017
ella.campbell@regeneron.com
View original
content:http://www.prnewswire.com/news-releases/regeneron-ranked-2-in-science-magazines-top-biopharma-companies-to-work-for-300945347.html
SOURCE Regeneron Pharmaceuticals, Inc.